Strattera Alternatives Compared
| Strattera | Adderall | Vyvanse |
|
|---|
| Strattera (atomoxetine) | Adderall (amphetamine / dextroamphetamine) | Vyvanse (lisdexamfetamine) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Strattera is a medication used for the treatment of ADHD. It is not a controlled substance and appears to have no abuse potential or discontinuation syndrome on withdrawal. Prescribed for ADHD... View more |
Prescription only
Adderall is a combination of four different amphetamine salts and may be used to improve attention, focus, or reduce impulsive behaviors in children over the age of 3 and adults with ADHD. It can... View more |
Prescription only
Vyvanse is a stimulant used for the treatment of ADHD to reduce symptoms such as impulsiveness and hyperactivity and to increase attention. It can also help increase the number of binge-free days per... View more |
Related suggestions ADHD (Attention Deficit Hyperactivity Disorder)
|
|||||||||||||||||||||||
| More about Strattera (atomoxetine) | More about Adderall (amphetamine / dextroamphetamine) | More about Vyvanse (lisdexamfetamine) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Strattera has an average rating of 5.3 out of 10 from a total of 534 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 39% reported a negative effect. |
Adderall has an average rating of 7.4 out of 10 from a total of 498 ratings on Drugs.com. 65% of reviewers reported a positive effect, while 17% reported a negative effect. |
Vyvanse has an average rating of 7.4 out of 10 from a total of 965 ratings on Drugs.com. 65% of reviewers reported a positive effect, while 15% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Strattera prices |
View all Adderall prices |
View all Vyvanse prices |
||||||||||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
Other amphetamine / dextroamphetamine brands include: Adderall XR, Mydayis |
N/A |
||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
40 hours |
34 hours |
1 hour |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 359 drugs are known to interact with Strattera:
|
A total of 214 drugs are known to interact with Adderall:
|
A total of 390 drugs are known to interact with Vyvanse:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
November 26, 2002 |
January 19, 1960 |
February 23, 2007 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.